Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1953 2
1954 4
1956 1
1957 2
1958 2
1959 1
1961 2
1962 2
1963 5
1964 1
1965 2
1968 1
1969 1
1974 1
1975 3
1976 5
1977 4
1978 2
1981 1
1982 2
1983 2
1984 2
1985 4
1986 7
1987 3
1988 8
1989 6
1990 4
1991 11
1992 4
1993 10
1994 7
1995 1
1996 7
1997 5
1998 6
1999 9
2000 6
2001 11
2002 3
2003 6
2004 7
2005 11
2006 10
2007 6
2008 16
2009 10
2010 17
2011 9
2012 26
2013 23
2014 26
2015 18
2016 22
2017 20
2018 20
2019 20
2020 22
2021 30
2022 24
2023 23
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

497 results

Results by year

Filters applied: . Clear all
Page 1
Langerhans cell sarcoma: a systematic review.
Howard JE, Dwivedi RC, Masterson L, Jani P. Howard JE, et al. Cancer Treat Rev. 2015 Apr;41(4):320-31. doi: 10.1016/j.ctrv.2015.02.011. Epub 2015 Mar 9. Cancer Treat Rev. 2015. PMID: 25805533 Review.
Langerhans cell sarcoma (LCS) is a rare malignant tumour of Langerhans cells with a poor outcome. ...Bone marrow transplant appears to be the most reliable treatment in terms of outcome especially in disseminated disease however has well known patient
Langerhans cell sarcoma (LCS) is a rare malignant tumour of Langerhans cells with a poor outcome. ...Bone marrow
Histiocytic disorders.
McClain KL, Bigenwald C, Collin M, Haroche J, Marsh RA, Merad M, Picarsic J, Ribeiro KB, Allen CE. McClain KL, et al. Nat Rev Dis Primers. 2021 Oct 7;7(1):73. doi: 10.1038/s41572-021-00307-9. Nat Rev Dis Primers. 2021. PMID: 34620874 Free PMC article. Review.
Prior classification schemes align disease designation with terminal phenotype: for example, Langerhans cell histiocytosis (LCH) shares CD207(+) antigen with physiological epidermal Langerhans cells. ...The title of this Primer (Histiocytic disorders) was cho …
Prior classification schemes align disease designation with terminal phenotype: for example, Langerhans cell histiocytosis (LC …
Histiocytic Diseases.
Moore PF. Moore PF. Vet Clin North Am Small Anim Pract. 2023 Jan;53(1):121-140. doi: 10.1016/j.cvsm.2022.07.010. Epub 2022 Oct 19. Vet Clin North Am Small Anim Pract. 2023. PMID: 36270835 Review.
Canine cutaneous histiocytomas originate from Langerhans cells. Multiple histiocytomas are referred to as cutaneous Langerhans cell histiocytosis. Feline pulmonary Langerhans cell histiocytosis causes respiratory failure owing to extensive lung …
Canine cutaneous histiocytomas originate from Langerhans cells. Multiple histiocytomas are referred to as cutaneous Langerhans
Langerhans cell sarcoma of the head and neck.
Howard JE, Masterson L, Dwivedi RC, Jani P. Howard JE, et al. Crit Rev Oncol Hematol. 2016 Mar;99:180-8. doi: 10.1016/j.critrevonc.2015.12.017. Epub 2016 Jan 2. Crit Rev Oncol Hematol. 2016. PMID: 26777877 Review.
Head and neck Langerhans cell sarcoma (HNLCS) is a rare malignant tumor carrying a poor prognosis. ...
Head and neck Langerhans cell sarcoma (HNLCS) is a rare malignant tumor carrying a poor prognosis. ...
Langerhans cell sarcoma involving skin and showing epidermotropism: A comprehensive review.
Ronen S, Keiser E, Collins KM, Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Prieto VG, Hymes S, Medeiros LJ, Torres-Cabala CA. Ronen S, et al. J Cutan Pathol. 2021 Apr;48(4):547-557. doi: 10.1111/cup.13803. Epub 2020 Sep 7. J Cutan Pathol. 2021. PMID: 32644218 Review.
Langerhans cell sarcoma (LCS) is rare and aggressive; patients have an overall survival rate of less than 50%. We present a 62-year-old man with a history of superficial spreading melanoma of the upper back with sentinel lymph node metastasis, Langerhans
Langerhans cell sarcoma (LCS) is rare and aggressive; patients have an overall survival rate of less than 50%. We prese
Langerhans cell sarcoma.
Ferringer T, Banks PM, Metcalf JS. Ferringer T, et al. Am J Dermatopathol. 2006 Feb;28(1):36-9. doi: 10.1097/01.dad.0000146314.52378.c2. Am J Dermatopathol. 2006. PMID: 16456323
Proliferations of Langerhans cells can be histologically divided into cytologically benign Langerhans cell proliferations, which include the clinical syndromes of Langerhans cell histiocytosis, and cytologically malignant Langerhans ce
Proliferations of Langerhans cells can be histologically divided into cytologically benign Langerhans cell proliferatio …
Langerhans Cell Histiocytosis and Langerhans Cell Sarcoma: Current Understanding and Differential Diagnosis.
Nakamine H, Yamakawa M, Yoshino T, Fukumoto T, Enomoto Y, Matsumura I. Nakamine H, et al. J Clin Exp Hematop. 2016;56(2):109-118. doi: 10.3960/jslrt.56.109. J Clin Exp Hematop. 2016. PMID: 27980300 Free PMC article. Review.
Langerhans cell (LC) histiocytosis (LCH) and LC sarcoma (LCS) are proliferative processes consisting of cells having morphologic and phenotypic features of Langerhans cells (LCs), although the latter may have lost some of these features. ...In addition
Langerhans cell (LC) histiocytosis (LCH) and LC sarcoma (LCS) are proliferative processes consisting of cells having mo
A review of histiocytic diseases of dogs and cats.
Moore PF. Moore PF. Vet Pathol. 2014 Jan;51(1):167-84. doi: 10.1177/0300985813510413. Vet Pathol. 2014. PMID: 24395976 Review.
Histiocytic proliferative disorders are commonly observed in dogs and less often cats. Histiocytic disorders occur in most of the dendritic cell (DC) lineages. Canine cutaneous histiocytoma originates from Langerhans cells (LCs) indicated by expression of CD1a, CD11 …
Histiocytic proliferative disorders are commonly observed in dogs and less often cats. Histiocytic disorders occur in most of the dendritic …
Langerhans cell sarcoma with BRAF-V600E mutation and hemophagocytosis: An autopsy report.
Madakshira MG, Sharma N, Malhotra P, Bal A. Madakshira MG, et al. Indian J Cancer. 2022 Jan-Mar;59(1):119-122. doi: 10.4103/ijc.IJC_749_20. Indian J Cancer. 2022. PMID: 35645053 Free article.
Langerhans cell sarcoma (LCS) is a rare high-grade neoplasm of langerhans cell phenotype having unambiguous malignant cytological features. ...
Langerhans cell sarcoma (LCS) is a rare high-grade neoplasm of langerhans cell phenotype having unambiguo
Langerhans cell sarcoma of the vulva: Case report and review of the literature.
Tillit S, Carbajal-Mamani S, Zlotecki R, Yang LJ, Esnakula A, Jacqueline C, Goicoechea JC. Tillit S, et al. Gynecol Oncol Rep. 2020 Apr 15;32:100570. doi: 10.1016/j.gore.2020.100570. eCollection 2020 May. Gynecol Oncol Rep. 2020. PMID: 32346590 Free PMC article.
Langerhans cell sarcoma (LCS) is a rare, malignant neoplastic disorder of Langerhans cells thought to arise from antecedent Langerhans cell histiocytosis (LCH) or de novo. ...
Langerhans cell sarcoma (LCS) is a rare, malignant neoplastic disorder of Langerhans cells thought to arise from
497 results